43 filings
Page 2 of 3
6-K
nd1uz21t
30 Apr 21
Current report (foreign)
8:00am
6-K
e3s8t1efk wuvskqud
6 Apr 21
Stealth Biotherapeutics Reports Fiscal Year 2020 Financial Results and Recent Business Highlights
8:06am
6-K
g2gvxgct fj46tv
11 Feb 21
Securities Purchase Agreement
8:04am
6-K
b1kckx3dqw5ym94 ue
7 Dec 20
Stealth BioTherapeutics Announces Appointment of Eve E. Slater, M.D., F.A.C.C. to its Board of Directors
4:20pm
6-K
nmbkhsb v3y
23 Nov 20
Securities Purchase Agreement
4:05pm
6-K
w7iowd 8jzs04mr
19 Nov 20
Current report (foreign)
5:16pm
6-K
7xlsaheuz
5 Nov 20
Stealth Biotherapeutics Reports Third Quarter 2020 Financial Results and Recent Business Highlights
8:06am
6-K
3bgks5nb3lg ics9zm4l
4 Nov 20
6-K for Transaction
5:18pm
6-K
58svrc6i77ob v2hqk
7 Aug 20
Current report (foreign)
12:00am
6-K
rpvg bhpe7omibmu
6 Aug 20
Stealth Biotherapeutics Reports Second Quarter 2020 Financial Results and Recent Business Highlights
8:00am
6-K
9eamqan dtjiknpoy
3 Jun 20
Current report (foreign)
4:06pm
6-K
1ft7cx9b
7 May 20
Stealth Biotherapeutics Reports First Quarter 2020
8:20am
6-K
ch6wr3eupxpj4c1at
13 Apr 20
Stealth Biotherapeutics Announces $20 Million Financing to
8:38am
6-K
56xl2 laufxwm6
3 Apr 20
Current report (foreign)
4:02pm
6-K
da1d11lokh9g0 gkam
16 Mar 20
Current report (foreign)
7:47am
6-K
75tll1gpy92pp7l1rs
7 Jan 20
Current report (foreign)
5:18pm
6-K
76yejyxhyr
20 Dec 19
Stealth BioTherapeutics Provides Update on Phase 3 Trial of Elamipretide in Primary Mitochondrial Myopathy
5:09pm
6-K
m1jaui8a
14 Nov 19
Stealth Biotherapeutics Reports Third Quarter 2019
8:00am
6-K
jl0ki7u1egpj csf
10 Oct 19
Alexion and Stealth Announce Agreement for Option toCo-Develop and Commercialize Late-Stage Therapy for Mitochondrial Diseases
8:15am
6-K
x3bs1p8
3 Sep 19
Stealth Biotherapeutics Announces Appointment of Robert
5:20pm